Preliminary research reports improvements with N-acetyl glucosamine as an added therapy in inflammatory bowel disease.
Further scientific evidence is necessary before a recommendation can be made.
Preliminary research reports improvements with N-acetyl glucosamine as an added therapy in inflammatory bowel disease.
Further scientific evidence is necessary before a recommendation can be made.